Myriad Genetics Inc. (MYGN)
Trading Center
Loading...
Symbols:
MYGN Forum Topics
- All Comments on MYGN
- General Discussion on MYGN
- Myriad Genetics, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript [view article]
- Will Myriad Genetics Keep Its Momentum? [view article]
- In Tech We Trust - Fast Money Recap (6/20/08) [view article]
- Cancer Stocks on the Go: Winners and Losers [view article]
- GM an Unlikely Hero - Fast Money Recap (7/1/08) [view article]
- Myriad Genetics: I Told You So [view article]
- Myriad Genetics: Another Alzheimer's Compound Goes Down [view article]
- Will Wal-Mart Heat Up Chile? Fast Money (6/17/08) [view article]
- Myriad Options on Alzheimers Disease [view article]
- Friday Options Outlook (Update): SOLF, TIN, MYGN, MSFT, DNA, DRYS, HRS, DO, JCG, HHH [view article]
- Five Biotech Stocks to Weather a Down Market [view article]
- Fast Money Recap, 4/7/08: Is Energy Topping? [view article]
loading ...Recent MYGN Articles
- Will Myriad Genetics Keep Its Momentum?
- GM an Unlikely Hero - Fast Money Recap (7/1/08)
- Myriad Genetics: I Told You So
- Monday Options Update: C, MYGN, TSN, LLTC, F, GM, BEC, RNWK
- Myriad Genetics: Another Alzheimer's Compound Goes Down
- Bernanke, the Greatest Speculator - Fast Money (6/25/08)
- BioMarin, Myriad, and Regeneron Show a Quiet Strength
- In Tech We Trust - Fast Money Recap (6/20/08)
- Pfizer on a Respirator - Fast Money Recap (6/18/08)
- Will Wal-Mart Heat Up Chile? Fast Money (6/17/08)
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Myriad Genetics, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript [view article]
Nice to see that Myriad is going stronger, and really hope that the Azixa will be a blockbuster too. And remeber the small company involved in Azixa. Epicept EPCT, quoted on nasdaq and OMX stockholm, tot cap. 35-40 mUSD, will be a very nice investment since the just got OK, for Ceplene in Europe. ReplyWill Myriad Genetics Keep Its Momentum? [view article]
I am a bit confused as well -- if they have no drugs that are near production how do they "have a fairly solid stream of revenues from their current drugs"? Their stream of revenue comes from genetic testing -- not current drugs. It is difficult to agree with your position when you do not even have basic knowledge on the companies operations. ReplyJefferson
In Tech We Trust - Fast Money Recap (6/20/08) [view article]
staticrhetoric.com/blo...ARTICLE ON STEVE JOBS AS WILLY WONKA AT THE APPLE FACTORY Reply
Cancer Stocks on the Go: Winners and Losers [view article]
I agree with paviov, However I would like to know about the new developments the phase II and III studies that are going well, where is the advancement taking place, how close to a cure, what company has the potential winning drug ?? ReplyWill Myriad Genetics Keep Its Momentum? [view article]
Do you know anything about Myriad?You said "Myriad does have a fairly solid stream of revenues from their current drugs" .... THEY DO NOT HAVE A DRUG ON THE MARKET OR GET ROYALTIES ON A DRUG - they sell diagnostics
YOU SAID "One possible issue that I see for Myriad based solely upon my knowledge of market psychology is that its stock price is very close to its 52 week high" ...WHAT ARE YOU TALKING ABOUT? THEY ARE AT AN ALL TIME HIGH not a "52-Week High".
THIS IS ALL ABOUT AN UGLY SHORT-SQUEEZE on mid-tier diagonostics company with a pipeline for a teazer.
Reply
Tiedeman
GM an Unlikely Hero - Fast Money Recap (7/1/08) [view article]
All of this crap is going lower. ReplyMyriad Genetics: I Told You So [view article]
Seadog - you are the one who should read English. The author shorted MYGN when it was 55, not 41. ReplyMyriad Genetics: Another Alzheimer's Compound Goes Down [view article]
why is bad news - discontinuation of drug in development - positive? save money that would have been spend to take the drug to next level and eventually onto the market?or is it investors knew before that the potential drug would not make it to the market or be a flop - hence have already factored this as low price. instead a small profit of 750 mio for phase 3 trials for +2 billion company Reply
Myriad Genetics: I Told You So [view article]
Here is a comparison between RS Investments Emerging Growth Fund and Nasdaq:finance.yahoo.com/q/bc...
Reply
Myriad Genetics: I Told You So [view article]
Being right or making money. On May 13th (when you told us so) the stock closed at $41.25. After the negative news it never broke below $45. How exactly did you make money on this put trade again? And you doubt the rationale that they will be profitable in FY09? They are roughly break even right now and have substantial net outstanding losses. The diagnostics business is hugely profitable (45% operating margins when not spending on their DTC campaign, 40% when they are) and growing rapidly. When you have sustainable revenue, cut spending on dead programs and pay no taxes, that falls to the bottom line. $60mm/45mm shares = $1.33 from cutting that program alone. Nothing in their pipeline warrants a trial near the scale that they undertook with Flurizan - that spend level is not coming back. Stick with collecting degrees, Doc. Maybe try English next - one datum leads but many data lead. ReplyMyriad Genetics: I Told You So [view article]
In investing, you have to go where the data leads you. The stock did not do as poorly as I thought when the results came out - so my target for going long went up from the twenties to the upper forties. Regarding my call - I don't recall saying I was brave. But at least braver than anonymous posters who hide behind pseudonyms. ReplyWill Wal-Mart Heat Up Chile? Fast Money (6/17/08) [view article]
after the nice people of Chile red...oops! read this....quote***In China, as elsewhere, we follow the Wal-Mart tradition of building our business one store and one customer at a time. We strive to provide our customers with friendly service and a wide selection of quality products at Every Day Low Prices. With each Wal-Mart store we bring advanced retail know-how to the local market. By fostering a healthy, competitive environment, we hope to constantly improve our business operations and customer service in order to contribute to the prosperity of the local economy.
Wal-Mart firmly believes in local procurement. We recognize that by purchasing quality products, we can generate more job opportunities, support local manufacturing and boost economic development. Over 95% of the merchandise in our stores in China is sourced locally. We have established partnerships with nearly 20,000 suppliers in China. At Wal-Mart, we always work with our suppliers to grow together. In August 2007, Wal-Mart once again secured the top spot of the 2007 Supplier Satisfaction Survey conducted by Business Information of Shanghai. Additionally, Wal-Mart directly exports about US$9 billion from China every year. The export volume by third party suppliers is also estimated to be over US$9 billion.***end of quote! Reply
Myriad Genetics: I Told You So [view article]
Ketan--NOW is the time to go long??? Nonsense, you could have bought the stock in the low '40's the week prior to announcement and owned the diagnostic business with a FREE option on Flurizan. The "call" on the P3 results was hardly brave as it was widely reported and expected to fail given prior results. Why on earth is now the time to buy it? What happened to "I will go long when it hits $25"... ReplyMyriad Genetics: I Told You So [view article]
Send me an email - I'll let you know if I can verify your identity. But, I agree that this is the time to go long on MYGN. ReplyMyriad Genetics: I Told You So [view article]
Forgot to ask: What was the break-even on your puts? The stock surged after the incredibly short-sighted shorts had to cover. Hedgies and banks probably manufactured half of that. Look at the longs...they get it. Reply